Trulieve Announces September 2026 Event Participation
Investors can find event details, access links, and presentations for Trulieve’s two September 2026 conferences featuring Christine Hersey and Kim Rivers.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Trulieve Cannabis (TRLV) will participate in two investor conferences in September 2026. On September 9, 2026, Chief Corporate Affairs and Strategy Officer Christine Hersey will join investor meetings at the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference. On September 29, 2026, Founder and CEO Kim Rivers will participate in investor meetings at the 5th Annual Roth Healthcare Opportunities Conference. Event details, access links, and presentations are available on Trulieve’s investor relations events webpage.
Details
News Market Reaction – TRLV
On Sep 2, the day this news came out, TRLV closed 1.02% below the previous close. Our momentum scanner recorded 5 alerts for this stock that day. Relative volume reached 1.6x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 2 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, September 9, 2026: Christine Hersey, Chief Corporate Affairs and Strategy Officer, will participate in investor meetings.
- 5th Annual Roth Healthcare Opportunities Conference, September 29, 2026: Founder and CEO Kim Rivers will participate in investor meetings.
Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/events
About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the NYSE under the symbol TRLV. For more information, please visit Trulieve.com.
Facebook: @Trulieve
Instagram: @Trulieve
X: @Trulieve
Investor and Media Contact
Christine Hersey, Chief Corporate Affairs and Strategy Officer
+1 (424) 202-0210
Christine.Hersey@Trulieve.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-september-2026-event-participation-302866770.html
SOURCE Trulieve Cannabis Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What investor conferences will Trulieve Cannabis (TRLV) attend in September 2026?
Trulieve Cannabis will attend the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference on September 9, 2026 and the 5th Annual Roth Healthcare Opportunities Conference on September 29, 2026, with executives participating in investor meetings.
Which Trulieve (TRLV) executives are participating in the September 2026 investor conferences?
At the ATB Cormark conference on September 9, 2026, Christine Hersey, Chief Corporate Affairs and Strategy Officer, will participate in investor meetings. At the Roth Healthcare Opportunities Conference on September 29, 2026, Founder and CEO Kim Rivers will participate in investor meetings.
How can investors access information and materials for Trulieve (TRLV) September 2026 events?
Information about Trulieve’s September 2026 events, including event details, available links, and slide presentations, can be found on the company’s investor relations events page at https://investors.trulieve.com/events.